Wang H et al.DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma.Int J Oncol 51:91-103 (2017).
Pajari AM et al.Ellagitannin-rich cloudberry inhibits hepatocyte growth factor induced cell migration and phosphatidylinositol 3-kinase/AKT activation in colon carcinoma cells and tumors in Min mice.Oncotarget 7:43907-43923 (2016).
Kim HJ et al.c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma.Sci Rep 6:38502 (2016).
Cozzo AJ et al.cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer.Springerplus 5:348 (2016).
Wright JW et al.The Hepatocyte Growth Factor/c-Met Antagonist, Divalinal-Angiotensin IV, Blocks the Acquisition of Methamphetamine Dependent Conditioned Place Preference in Rats.Brain Sci 2:298-318 (2012).
Castoldi R et al.Molecular characterization of novel trispecific ErbB-cMet-IGF1R antibodies and their antigen-binding properties.Protein Eng Des Sel 25:551-60 (2012).
Smotrov N et al.Development of a cell-based assay for measurement of c-Met phosphorylation using AlphaScreen technology and high-content imaging analysis.J Biomol Screen 14:404-11 (2009).